Evidence map›Paper›PMID 40337866›Full record

ArticleJCI insight2025

Rhinovirus as a driver of airway T cell dynamics in children with treatment-refractory recurrent wheeze.

Naomi Bryant, Lyndsey M Muehling, Kristin Wavell, W Gerald Teague, Judith A Woodfolk

Abstract read
In one paragraph

Article in JCI insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Naomi BryantDepartment of Medicine.
Lyndsey M MuehlingDepartment of Medicine.
Kristin WavellChild Health Research Center, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
W Gerald TeagueChild Health Research Center, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Judith A WoodfolkDepartment of Medicine.

Funding

Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Dina Gould Halme · 1987 to 2026
$72.1M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007496 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Michael G. Brown, Coleen A McNamara · 1995 to 2026
$10.2M
DUST MITE, COCKROACH AND CAT ALLERGENS IN HOUSES/ASTHMAR01AI020565 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI PLATTS-MILLS, THOMAS A. · 1985 to 2017
$7.1M
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to aU01AI100799 · NIAID · UNIVERSITY OF VIRGINIA · PI HEYMANN, PETER W, PLATTS-MILLS, THOMAS A. · 2012 to 2015
$5.3M
Hallmarks of Protective Immunity in Sequential Rhinovirus Infections in HumansU01AI125056 · NIAID · UNIVERSITY OF VIRGINIA · PI WOODFOLK, JUDITH A · 2016 to 2020
$4.1M
Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with AsthmaR01AI176171 · NIAID · UNIVERSITY OF VIRGINIA · PI Jie Sun, WILLIAM GERALD TEAGUE · 2023 to 2026
$2.7M
Protective and Pathogenic T Cells Responding to SARS-CoV-2 in Health and DiseaseR21AI160334 · NIAID · UNIVERSITY OF VIRGINIA · PI WOODFOLK, JUDITH A · 2021 to 2022
$444k
Exploring Amplified Th1 Responses and a Role for the IgE/Interferon Axis in Allergic Asthmatics Infected with RhinovirusR21AI138077 · NIAID · UNIVERSITY OF VIRGINIA · PI WOODFOLK, JUDITH A · 2019 to 2020
$437k
Immune Programs and Related T Cell Mechanisms of Pulmonary Complications After COVID-19 IllnessR56AI178669 · NIAID · UNIVERSITY OF VIRGINIA · PI WOODFOLK, JUDITH A · 2023 to 2023
$410k
NCI NIH HHS P30 CA044579NIAID NIH HHS R01 AI020565NIAID NIH HHS R01 AI176171NIAID NIH HHS R21 AI138077NIAID NIH HHS R21 AI160334NIAID NIH HHS R56 AI178669NIAID NIH HHS T32 AI007496NIAID NIH HHS U01 AI100799NIAID NIH HHS U01 AI125056
6 · The paper itself

Abstract

Severe asthma in children is notoriously difficult to treat, and its immunopathogenesis is complex. In particular, the contribution of T cells and relationships to antiviral immunity remain enigmatic. Here, we coupled deep phenotyping with machine learning methods to elucidate the dynamics of T cells in the lower airways of children with treatment-refractory recurrent wheeze, and examine rhinovirus (RV) as a driver. Our strategy revealed a T cell landscape dominated by type 1 and type 17 CD8+ signatures. Interrogation of phenotypic relationships coupled with trajectory mapping identified T cell migratory and differentiation pathways spanning the blood and airways that culminated in tissue residency, and involved transitions between type 1 and type 17 tissue-resident types. These dynamics were reflected in cytokine polyfunctionality. Use of machine learning tools to cross-compare T cell populations that were enriched in the airways of RV-positive children with those induced in the blood following experimental RV challenge precisely pinpointed RV-responsive signatures that contributed to T cell migratory and differentiation pathways. Despite their rarity, these signatures were also detected in the airways of RV-negative children. Together, our results underscore the aberrant nature of type 1 immunity in the airways of children with recurrent wheeze, and implicate an important viral trigger as a driver.

Indexed as

AsthmaPicornaviridae InfectionsRespiratory SoundsRhinovirusT-LymphocytesCD8-Positive T-LymphocytesChildChild, PreschoolCytokinesFemaleHumansMaleRecurrenceCytokinesImmunologyInfectious diseaseT cellsTh1 response

Identifiers

PMID40337866
PMCPMC12128989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.